← All diseases

Disease Atlas / Disease detail

Osteoporosis

An educational draft summarizing the definition, risk factors, diagnosis, management, and evidence interpretation of osteoporosis

osteoporosis · bone mineral density quantitative trait locus · osteoporosis, involutional · osteoporosis, postmenopausal

MONDO:0005298Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · b2b46abfedba

Disease category
Osteoporosis is a disease characterized by weakened bone strength and structure, leading to an increased risk of fractures.
Core mechanism
Aging, postmenopausal hormonal changes, nutritional deficiencies, certain diseases and medications, smoking, excessive alcohol consumption, and physical inactivity can be contributing factors.
Main causes · related factors
During the process of old bone being replaced by new bone, if bone resorption exceeds formation, bone mass and tissue strength decrease.
Representative patterns
The most characteristic clinical issue is fragility fractures occurring in the hip, spine, wrist, and other sites.
Individual differences
Advanced age, female sex, postmenopausal status, small body frame, family history, and low intake of calcium, vitamin D, and protein can increase risk; individual risks vary.
Diagnosis
There are usually no early symptoms, and the condition is often discovered at the time of the first fracture. As it progresses, it may be accompanied by a decrease in height or changes in posture.
Management
Diagnosis is made by comprehensively integrating medical history, fracture risk factors, physical examination, bone mineral density testing, and, if necessary, fracture risk assessment.
Treatment/Research Status
Bone mineral density values alone cannot definitively determine all fracture risks or the necessity for treatment; therefore, age, fracture risk factors, medications, and comorbidities must be interpreted together.
Read Evidence
The core of management is to comprehensively review nutrition, physical activity, smoking cessation and alcohol moderation, fall prevention, and appropriate pharmacological treatment, with the goal of preventing fractures.
Key Precautions
Current treatments may include medications that slow or halt bone loss and those that promote bone formation, with the choice depending on individual risk levels.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a Glance

Osteoporosis is a disease characterized by weakened bone strength and structure, leading to an increased risk of fractures.

The most characteristic clinical issue is fragility fractures occurring in the hip, spine, wrist, and other sites.

How the disease works

Aging, postmenopausal hormonal changes, nutritional deficiencies, certain diseases and medications, smoking, excessive alcohol consumption, and physical inactivity can be contributing factors.

During the process of old bone being replaced by new bone, if bone resorption exceeds formation, bone mass and tissue strength decrease.

Variations in presentation among individuals

Advanced age, female sex, postmenopausal status, small body frame, family history, and low intake of calcium, vitamin D, and protein can increase risk; individual risks vary.

The broad framework of diagnosis and management

There are usually no early symptoms, and the condition is often discovered at the time of the first fracture. As it progresses, it may be accompanied by a decrease in height or changes in posture.

Diagnosis is made by comprehensively integrating medical history, fracture risk factors, physical examination, bone mineral density testing, and, if necessary, fracture risk assessment.

Current status of treatment

Bone mineral density values alone cannot definitively determine all fracture risks or the necessity for treatment; therefore, age, fracture risk factors, medications, and comorbidities must be interpreted together.

The core of management is to comprehensively review nutrition, physical activity, smoking cessation and alcohol moderation, fall prevention, and appropriate pharmacological treatment, with the goal of preventing fractures.

Current treatments may include medications that slow or halt bone loss and those that promote bone formation, with the choice depending on individual risk levels.

How to read clinical trials

Observational studies related to osteoporosis may be registered on ClinicalTrials.gov, but the fact that they are registered or recruiting does not imply efficacy, approval, or that they constitute standard of care.

Points to verify during clinical consultations

In clinical practice, it is important to assess the significance of past fractures, current medications, menopausal/hormonal status, family history, diet and exercise, fall history, and test results.

Medical Guidance

This material is for educational purposes and is not intended as a guide for individual diagnosis or treatment. Please consult medical staff regarding personal health issues.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.